Home Newsfeeds HC Wainwright & Co. Reiterates Buy on ADMA Biologics, Maintains $4.5 Price Target

HC Wainwright & Co. Reiterates Buy on ADMA Biologics, Maintains $4.5 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates ADMA Biologics (NASDAQ:ADMA) with a Buy and maintains $4.5 price target.

byBenzinga Newsdesk

February 8, 2023

1 minute read

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates ADMA Biologics (NASDAQ:ADMA) with a Buy and maintains $4.5 price target.

Enviva Reports Minimal Impact From Hurricane Ian, Provides Details On 3Q And 4Q 2022 Expectations, And Updates 2022 Guidance

By Benzinga Newsdesk

October 3, 8:03 AM

Highlights: Reported that Hurricane Ian caused minimal impact to Enviva's operations, with all employees confirmed safe Provided third-quarter 2022 net loss guidance range of $15

EVA

News

Remark Holdings, Inc. Joins NVIDIA Metropolis Program To Accelerate The Delivery Of Smart City Projects; Shares Spike Higher

By Happy Mohamed

June 2, 9:02 AM

Remark Holdings, Inc. (NASDAQ:MARK), a leading provider of artificial intelligence ("AI")-powered video analytics solutions, announced it has joined the NVIDIA Metropolis program to accelerate the

MARK

DraftKings Stock Has Upside To Street Estimates, Analyst Says: Sports Betting Play Will ‘Benefit From Healthy Growth’

By Chris Katje

April 16, 10:44 AM

DraftKings stock is up over 100% in the last year. An analyst sees more upside ahead with new initiation on the sports betting leader.

Beyond Meat Q2 EPS $(1.53) Misses $(1.18) Estimate, Sales $147.04M Miss $151.18M Estimate

By Benzinga Newsdesk

August 4, 4:07 PM

Beyond Meat (NASDAQ:BYND) reported quarterly losses of $(1.53) per share which missed the analyst consensus estimate of $(1.18) by 29.66 percent. This is a 393.55 percent decrease over losses of $(0.31) per share from

BYND

HC Wainwright & Co. Reiterates Buy on ADMA Biologics, Maintains $4.5 Price Target

Related Posts

Enviva Reports Minimal Impact From Hurricane Ian, Provides Details On 3Q And 4Q 2022 Expectations, And Updates 2022 Guidance

Remark Holdings, Inc. Joins NVIDIA Metropolis Program To Accelerate The Delivery Of Smart City Projects; Shares Spike Higher

DraftKings Stock Has Upside To Street Estimates, Analyst Says: Sports Betting Play Will ‘Benefit From Healthy Growth’

Beyond Meat Q2 EPS $(1.53) Misses $(1.18) Estimate, Sales $147.04M Miss $151.18M Estimate